| Model Number |
7300TFX |
| Medical Device Problem Codes |
Adverse Event Without Identified Device or Use Problem (2993); Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Dyspnea (1816); Insufficient Information (4580)
|
| Date of Event |
12/04/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was learned through implant patient registry and investigation that a 29mm 7300tfx mitral valve was explanted after an implant duration of eight (8) years, and nine (9) months due to unknown reason.The explanted valve was replaced with a 29mm 11400m mitral valve.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital and patient family members) and is not received in the form of a conventional "customer complaint." the information reported may or may not be related to the edwards device.
|
| |
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: attempts have been made to obtain product for evaluation.No device was returned.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Event or Problem Description
|
|
It was learned through implant patient registry and investigation that a 29mm 7300tfx mitral valve was explanted after an implant duration of eight (8) years, and nine (9) months due to endocarditis, regurgitation, and degeneration.The patient presented dyspnea.The explanted valve was replaced with a 29mm 11400m mitral valve.The patient expired due to septic shock, profound coagulopathy and cardiogenic shock.
|
| |
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: updated sections b5, b7, g3, g6, h2, h6 (health effect - clinical code, device code).Based on the additional information obtained, the failure mode was due to endocarditis.H11.Corrected data: based on the additional information obtained, this event is no longer considered reportable and this correction is being submitted.
|
| |
|
Search Alerts/Recalls
|